Allogeneic stem cell transplantation as a new treatment option for patients with severe Bernard-Soulier Syndrome

Christina Rieger; Andreas Rank; Michael Fiegl; Johanna Tischer; Xaver Schiel; Helmut Ostermann; Hans-Jochem Kolb

doi:10.1055/s-0037-1612582

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2006; 95(01): 190-191
DOI: 10.1055/s-0037-1612582

Case Report

Schattauer GmbH

Allogeneic stem cell transplantation as a new treatment option for patients with severe Bernard-Soulier Syndrome

Christina Rieger

¹Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany

,

Andreas Rank

¹Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany

,

Michael Fiegl

¹Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany

,

Johanna Tischer

¹Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany

,

Xaver Schiel

¹Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany

,

Helmut Ostermann

¹Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany

,

Hans-Jochem Kolb

¹Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Bernard J, Soulier J P. Sur une nouvelle varieté de dystrophie thrombocytairehemorrhagipare congenitale. Semin Hop Paris 1948; 24: 3217.
2 Lopez JA, Andrews RK, Afshar-Kharghan V. et al. Bernard-Soulier-Syndrome. Blood 1998; 91: 4397-418.
3 Caen JP, Levy-Toledano S. Interaction between platelets and von Willebrand factor provides a new scheme for primary haemostasis. Nat New Biol 1973; 244: 159-60.
4 Andrews RK, José A, Berndt MC. Molecular mechanisms of platelet adhesion and Activation. Int J Biochem Cell Biol 1997; 29: 91-105.
5 Cuthbert RJ, Watson HH, Handa SI. et al. DDAVP shortens the bleeding time in Bernard-Soulier syndrome. Thromb Res 1988; 49: 649-50.
6 Kehmali S, Canatan D, Uysal Z. et al. DDAVP shortens bleeding time in Bernard-Soulier syndrome. Thromb Haemost 1994; 71: 675.
7 Greinacher A, Pötzsch B, Kiefel V. et al. Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von-WillebrandFactor. Ann Hematol 1993; 67: 149-50.
8 Linden MD, FrelingerA L, Barnard MR. et al. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 2004; 30: 501-11.
9 Carreras E. Early Complications after HSCT. In: The EBMT Handbook. Haematopoietic Stem Cell Transplantation. Apperly J, Carreras E, Gluckman E, Gratwohl A, Masszi T. 2004. Revised Edition. Forum Service Editore; Genua: 2004: 133-45.
10 Locatelli F, Rossi G, Balduini C. Hematopoietic stem-cell transplantation for the Bernard-Soulier-Syndrome. Ann Int Med 2003; 138: 79.